Literature DB >> 16736153

Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats.

Aly M Abdelrahman1, Catherine C Y Pang.   

Abstract

We investigated the effect of intermedin/adrenomedullin-2 (3 and 10 nmol/kg, i.v.), a member of the calcitonin gene-related peptide family, relative to the vehicle (0.9% NaCl) on mean circulatory filling pressure (index of venous tone) in conscious rats: intact (unblocked) or ganglionic blocked through treatment with mecamylamine (10 mg/kg, i.v.) and noradrenaline (4 microg/kg/min, i.v.). In intact rats, both doses of intermedin/adrenomedullin-2 reduced mean arterial pressure (-14+/-3, -30+/-3 mmHg), but did not alter mean circulatory filling pressure; the high dose also increased heart rate. In ganglionic-blocked rats, both doses decreased mean arterial pressure (-22+/-3, -46+/-5 mmHg) and the high dose also decreased mean circulatory filling pressure (-2.81+/-0.82 mmHg), but neither dose affected heart rate. The vehicle did not have any effects in any of the groups. In addition, intermedin/adrenomedullin-2 did not have any effect on blood volume in both intact and ganglion-blocked rats. The results show that intermedin/adrenomedullin-2 is a dilator of arterial resistance and capacitance vessels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736153     DOI: 10.1007/s00210-006-0076-z

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  Influence of urocortin and corticotropin releasing factor on venous tone in conscious rats.

Authors:  Aly M Abdelrahman; Su Lin Lim; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2005-03-07       Impact factor: 4.432

Review 2.  Measurement of body venous tone.

Authors:  C C Pang
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Sep-Oct       Impact factor: 1.950

3.  Determination of the circulating red cell volume in man by radioactive chromium.

Authors:  K STERLING; S J GRAY
Journal:  J Clin Invest       Date:  1950-12       Impact factor: 14.808

Review 4.  The molecular pharmacology of CGRP and related peptide receptor subtypes.

Authors:  C Juaneda; Y Dumont; R Quirion
Journal:  Trends Pharmacol Sci       Date:  2000-11       Impact factor: 14.819

5.  Venodilator action of an organotransition-metal nitrosyl complex.

Authors:  Kenneth S Poon; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2002-02-01       Impact factor: 4.432

6.  Effect of nociceptin/orphanin FQ on venous tone in conscious rats.

Authors:  Aly M Abdelrahman; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2002-11-29       Impact factor: 4.432

7.  Effects of vasodilator drugs on venous tone in conscious rats.

Authors:  H M D'Oyley; R Tabrizchi; C C Pang
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

8.  Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator.

Authors:  Yoshio Takei; Koji Inoue; Maho Ogoshi; Tetsushi Kawahara; Hideo Bannai; Satoru Miyano
Journal:  FEBS Lett       Date:  2004-01-02       Impact factor: 4.124

9.  Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.

Authors:  Jaesook Roh; Chia Lin Chang; Alka Bhalla; Cynthia Klein; Sheau Yu Teddy Hsu
Journal:  J Biol Chem       Date:  2003-11-13       Impact factor: 5.157

10.  Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats.

Authors:  Xing Cheng; Xiao Shuo Cheng; Catherine C Y Pang
Journal:  Eur J Pharmacol       Date:  2003-06-06       Impact factor: 4.432

View more
  4 in total

Review 1.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

Review 2.  The pharmacology of adrenomedullin 2/intermedin.

Authors:  Yanguo Hong; Debbie L Hay; Remi Quirion; David R Poyner
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems.

Authors:  D Bell; B J McDermott
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

4.  Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.

Authors:  L Jolly; J E March; P A Kemp; T Bennett; S M Gardiner
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.